Tumorgrafts as in vivo surrogates for women with ovarian cancer. - Wikidata - wikimedia - TriplyDB

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

http://www.wikidata.org/entity/Q37626455

about

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Emerging and Evolving Ovarian Cancer Animal Models Molecular and clinical implementations of ovarian cancer mouse avatar models A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts Prioritizing therapeutic targets using patient-derived xenograft models Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.Patient-derived xenograft models in gynecologic malignancies An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer Spherical cancer models in tumor biology.Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.The promise and challenge of ovarian cancer models.AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer Beyond genomics: critical evaluation of cell line utility for ovarian cancer research Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer.Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.Patient-derived xenografts as tools in pharmaceutical development.Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.Orthotopic Model of Ovarian Cancer.WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death.Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts Human tissue models in cancer research: looking beyond the mouse.Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

P2860

Q26780387-C4944A17-FF7A-431F-A75D-9357E30B4E3C Q26783909-C739264A-262C-4E83-9540-5D2128387A72 Q26786724-AB1B3311-5A03-456B-8FC8-7F11395DAF58 Q27346392-2BF61A9E-969C-4DA7-AE0A-BD2B7A92FD2B Q28083993-61D49035-0905-4A1B-9C85-D13A5442D4CD Q30409503-C617ED07-E0F2-48DB-9401-22AD3C6A0518 Q30423597-2F465F18-E4FB-4D98-B896-0CD3E16BB79A Q33842769-C6D750AA-6F75-49E3-93D8-CF3763B5C1CA Q34141193-2F8FA136-9AD2-4283-926D-8CE0AC2F71B6 Q34458291-A261F125-1BC5-44CD-97FA-0CC506115AB7 Q35023931-33C43B83-11B9-465F-9F52-0384F38A48D8 Q35592388-0FD3D329-1CD7-47E7-A18A-036B39C424B3 Q35592860-692F62D7-3157-4E02-A203-34AE3B094C71 Q35760892-4E62587D-BBA9-43F3-985B-E263E7982BA5 Q35771750-7687536A-1811-4022-B34E-2BC3101F63B0 Q35961381-C957CED6-75FB-4865-8E49-85E5FEE68B04 Q36104020-51B8E333-6005-4114-9AEB-889F5DFD7869 Q36123789-46E289FC-FA55-4196-B7F6-7090ACCE810D Q36272668-BA8C9B2D-EB8F-42E0-9944-040A616602F8 Q36414048-DE0F4D01-1A61-4B5A-98D9-478694AD3DB6 Q36420683-5BF06519-4D8F-40BC-8F39-D54F9A8EB35D Q36436803-39A0F979-F12A-4E68-8393-2BA4F6FFCC38 Q36905898-02BCFEC0-4F26-4289-9063-0467B84AC903 Q37272622-F04A83E3-8553-4D7A-82C0-09F402D28029 Q37295618-8678661A-2022-4D5A-A3CE-B5A84D3F1FC7 Q37353774-373DCA47-4D3D-4184-9481-33BC463DEA4C Q37362776-94CAC723-71AC-4874-9084-2AD14A19524C Q37500390-912D905F-B35D-408C-9581-06DB589EE775 Q37558633-04F5EFB6-B613-441D-8C8C-8BB5F2B7B153 Q37620476-0607EE82-A02D-4EBB-9E92-AC3980475122 Q37726508-837DDA62-124D-4562-A949-D6BB7E74D97D Q38605020-B981E376-1648-457A-B2A9-5C5C9DB8CB38 Q38722976-142B22E2-38E9-47D6-AF23-453ED8719AEB Q38732336-12AA38AE-A924-4151-8D0F-4C9C6E86BACC Q39028384-B57AE2C5-919B-4D5A-A1AF-E98E70344467 Q39178435-2AF169BD-3838-4EFB-806D-C0190FC6AB60 Q41074649-A124E4FB-203D-4994-BB13-6B7B09753F41 Q42344756-1D2D140A-1DFB-4DA6-BDC8-C871C9F51945 Q42346523-A994F961-31F5-49E0-B14B-33920DFC24ED Q45068320-03D641ED-9EC8-4C00-B8D0-F87F80EE5AA1

P2860

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

http://www.wikidata.org/entity/Q37626455

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@en

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@nl

type

label

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@en

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@nl

prefLabel

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@en

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

@nl

P1433

Q37626455-254A9A3E-9BEC-4045-AD4D-8460E3DBE61C

P1476

Q37626455-D3411309-9EDC-4D23-9B2F-D5249E4BBE02

P2093

Q37626455-19D15495-D7A7-4859-839A-535804248D2C

Q37626455-1E380CA2-BEDD-4EDD-B53E-A0B1EAFFB4FD

Q37626455-22A8D9A4-0C10-4164-9B88-183AA337B64E

Q37626455-26CE46D4-1961-4A09-9B91-72701FBF87A3

Q37626455-2B79085A-BB66-435D-B480-A4D3AB54FCA5

Q37626455-2D3042F2-B59C-4E3B-9A8C-F6B9F73E7AB4

Q37626455-3A9FFF83-EB60-4313-B124-74A2ED851093

Q37626455-40D2F6EC-8BBB-47E4-92C8-0593C1F972F7

Q37626455-513076DB-386C-4EFF-9AFB-315989AF8A39

Q37626455-628D8A12-44D4-4E9B-984E-88FF7CCBD582

P2860

Q37626455-03ACFD33-8589-4881-9245-A360918028A3

Q37626455-0DFD1EA2-77F8-4713-BC48-972A47840976

Q37626455-1775DED2-125F-460D-879A-1DC5D9F07E7A

Q37626455-2671DBF4-445F-4BCD-AD65-88862895F858

Q37626455-36F99840-DD0F-4191-9A1B-97E838E935BB

Q37626455-36FD6FE3-B753-47DA-9C96-1EE11BD287EC

Q37626455-3EFFF9C0-E819-4CB5-8FE1-084BEB97A926

Q37626455-47CAA7FD-1706-4633-8C9B-7700816A78DA

Q37626455-4C818B15-F3E8-435F-A57F-B8DE48D46D7A

Q37626455-53124678-4015-461F-A127-616C8F8B9C62

P304

Q37626455-8C84478C-A9DB-4486-8A54-CD0B54514EAB

P31

Q37626455-6BB1A924-E4B3-4110-AC14-981FBC5E8879

P356

Q37626455-09D22B23-D99A-44D5-AE0A-7DA25E033EF8

P407

Q37626455-1AAC9CD7-38DC-4884-8794-BB3B7FE7DB1E

P433

Q37626455-183A9229-5D72-4D4E-8BCD-BB24B47ECDDD

P478

Q37626455-C4A6A30E-C6AD-436A-8B2D-20016E6AFCD3

P50

Q37626455-667C7027-A8D2-476E-AE04-88BE3B478872

Q37626455-9D4465D9-E471-4272-8DF2-C2C000313106

Q37626455-CDB882CB-2394-4EA2-A320-56335A558A33

P577

Q37626455-05ABFE5B-158E-45EC-9FC6-DD4E042E15D7

P698

Q37626455-A7FE5CAA-2F3A-4948-96E3-93C4718E8CBF

P921

Q37626455-C6071416-1C04-4298-8CEF-5745C426C0E8

P932

Q37626455-C2728D29-BD4D-4104-B072-111DBC629FCF

P356

1078-0432.CCR-13-2611

P1433

Clinical Cancer Research

P1476

Tumorgrafts as in vivo surrogates for women with ovarian cancer

@en

P2093

Amanika Kumar

http://www.w3.org/2001/XMLSchema#string

Ann L Oberg

http://www.w3.org/2001/XMLSchema#string

Beth Y Karlan

http://www.w3.org/2001/XMLSchema#string

Jann N Sarkaria

http://www.w3.org/2001/XMLSchema#string

Karin M Goodman

http://www.w3.org/2001/XMLSchema#string

Kimberly R Kalli

http://www.w3.org/2001/XMLSchema#string

Kristina A Butler

http://www.w3.org/2001/XMLSchema#string

Lynn C Hartmann

http://www.w3.org/2001/XMLSchema#string

Marc A Becker

http://www.w3.org/2001/XMLSchema#string

Mariam AlHilli

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies

NIH Image to ImageJ: 25 years of image analysis

Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization

Cluster analysis and display of genome-wide expression patterns

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2013

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Normalization of cDNA microarray data

Phenotypic instability of Saos-2 cells in long-term culture

Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period

P304

1288-1297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-2611

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Scott H Kaufmann

Matthew J Maurer

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24398046

http://www.w3.org/2001/XMLSchema#string

P921

P932

3947430

http://www.w3.org/2001/XMLSchema#string